Skip to content

Treatment of Compound Tibia Fracture With a Microvascular Latissimus Dorsi Flap and the Ilizarov Technique

Treatment of Compound Tibia Fracture With a Microvascular Latissimus Dorsi Flap and the Ilizarov Technique: a Cross-sectional Study of Long-term Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02369991
Enrollment
9
Registered
2015-02-24
Start date
2014-06-30
Completion date
2015-02-28
Last updated
2015-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reconstructive Surgical Procedure

Keywords

latissimus dorsi flap, bone transport, bone reconstruction, tibia, tibial fracture

Brief summary

This study assesses the long-term results of compound tibial reconstruction treated with a microvascular latissimus dorsi flap and bone transport technique during the last 25 year in Helsinki University central Hospital.

Detailed description

A retrospective review of hospital records was conducted to chart the clinical and operational characteristics of patient. Patients current condition is assessed by applying two function-related (Disabilities of the Arm, Hand and Shoulder, DASH; Lower Extremity Functional Scale, LEFS) and a health-related quality of life (the 15-dimensions, 15D) questionnaires. The patients received the questionnaires by mail. A written informed consent was obtained from the participants. The obtained data was computerized and analyzed.

Interventions

PROCEDUREReconstructive surgery

Patients were treated with free latissimus dorsi flap and bone transport technique

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 15 years. * Patients with acute compound tibial fracture or sequela treated with free latissimus dorsi flap and bone transport.

Exclusion criteria

* Deceased. * Patients under 15 years of age.

Design outcomes

Primary

MeasureTime frameDescription
Disabilities of the Arm, Shoulder and Hand (DASH)10-25 yearsAssesses the function of the donor site
The 15-Dimensions Health-Related Quality of Life (HRQoL) instrument.10-25 yearsAssesses the HRQoL
Lower Extremity Functional Scale (LEFS)10-25 yearsAssesses the function of the reconstructed limb

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026